Youth dies, another rescued after car plunges into dam waters in Udupi

[email protected] (CD Network)
July 20, 2015

Udupi, Jul 20: A youth met watery grave, while another one was rescured after a speeding car plunged into a dam waters at Mattu village in Udupi district in the weekend night.

car1

Satish Shetty (35), a resident of Karkala, was driving his Maruti Omni car towards his in-laws’ house in Mattu when the tragedy took place.

It is believed that Shettly lost control over his speeding vehicle due to slippery road and poor visibility amidst heavy rain at around 11:30 p.m.

Prashant Mattu, who was also on board the car, was rescued by the local residents after the tragedy. He is recuperating at a hospital.

The body of Shetty was retrieved only on Monday morning. A case has been registered at jurisdictional Kaup police station and investigations are on.

Comments

Palma
 - 
Monday, 9 May 2016

Wonderful work! That is the kind of information that should be shared around the web.

Disgrace on the search engines for now not positioning this
publish upper! Come on over and consult with my site .
Thank you =)

my weblog ... auto
transport: http://it.wsgiga.com/afldir.com

Phillis
 - 
Wednesday, 6 Jan 2016

Hi there, i read your blog from time to time and i own a similar one and i was just curious
if you get a lot of spam feedback? If so how do you reduce
it, any plugin or anything you can advise? I get so much lately it's driving
me mad so any assistance is very much appreciated.

Also visit my weblog - uncover orlando holiday: http://www.hope365.org/?document_srl=638929

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 6,2020

Bengaluru, Jan 6: There is a wide spread criticism by the Janata Dal(S) and Congress leaders over a proposal to rename Ramanagaram district as New (Nava) Bengaluru, Karnataka Chief Minister CM Yediyurappa said on Monday.

“An unnecessary discussion on renaming Ramanagaram is under way. There is no thought before the government over renaming," The CM accused the Congress and JD(S) leaders of indulging in baseless discussion to mislead the people and to remain relevant. "There is no such agenda before the government. It is a joke that JD(S) and Congress leaders are starting a fight over it.”

The Chief Minister’s clarification came after criticism by former Chief Minister HD Kumaraswamy, who carved out the Ramanagaram district when he was Chief Minister, and former Minister DK Shivakumar whose Kanakapura constituency is in Ramanagaram district, after Deputy Chief Minister CN Ashwath Narayan said Ramanagaram could be renamed as Nava Bengaluru to increase investments prospects.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 19,2020

Hubli, Feb 19: The Karnataka Police on Wednesday registered a case against unknown persons for assaulting three Kashmiri students in the court premises here.

A suo motu FIR has been registered at Vidyanagar police station of Hubli in which assault charges have been filed against 10 to 15 unknown people.

It can be recalled that on February 17 these three Kashmiri students were attacked in court premises after they were produced in court on charges of sedition.

The Kashmiri students were arrested here on February 15 after their video in which they are seen allegedly raising pro-Pakistan slogans went viral.

The students were studying at the KLE Institute of Technology on a central government scholarship.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.